Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Baumann

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 31, 2018
[Troubleshooting in Patients with Implanted Pacemaker and ICD]Dorothee Meyer Zu Vilsendorf, Bert Hansky, Philipp Baumann, et al.
Anti-Cancer Drugs|August 19, 2006
Synergistic antimyeloma effects of zoledronate and simvastatinRalf Schmidmaier, Meral Simsek, Philipp Baumann, et al.
Onkologie|September 22, 2011
Aplastic crisis as primary manifestation of systemic lupus erythematosusPhilipp Baumann, Andreas Völkl, Michael Bäuerle, et al.
Anti-Cancer Drugs|February 26, 2009
Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001Philipp Baumann, Hilke Hagemeier, Sonja Mandl-Weber, et al.
Anti-Cancer Drugs|March 14, 2007
Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cellsPhilipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2007
Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathwaysLeander Gaul, Sonja Mandl-Weber, Philipp Baumann, et al.
Children (Basel, Switzerland)|November 27, 2024
Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill ChildrenRafael Muff, Verena Gotta, Vera Jaeggi, et al.
Anti-Cancer Drugs|October 1, 2011
Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myelomaPhilipp Baumann, Laura Schneider, Sonja Mandl-Weber, et al.
Frontiers in Plant Science|November 12, 2020
A Non-destructive Method to Quantify Leaf Starch Content in Red CloverLea Antonia Frey, Philipp Baumann, Helge Aasen, et al.
Experimental Cell Research|August 3, 2007
Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cellsPhilipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|October 31, 2018
[Troubleshooting in Patients with Implanted Pacemaker and ICD]Dorothee Meyer Zu Vilsendorf, Bert Hansky, Philipp Baumann, et al.
Anti-Cancer Drugs|August 19, 2006
Synergistic antimyeloma effects of zoledronate and simvastatinRalf Schmidmaier, Meral Simsek, Philipp Baumann, et al.
Onkologie|September 22, 2011
Aplastic crisis as primary manifestation of systemic lupus erythematosusPhilipp Baumann, Andreas Völkl, Michael Bäuerle, et al.
Anti-Cancer Drugs|February 26, 2009
Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001Philipp Baumann, Hilke Hagemeier, Sonja Mandl-Weber, et al.
Anti-Cancer Drugs|March 14, 2007
Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cellsPhilipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2007
Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathwaysLeander Gaul, Sonja Mandl-Weber, Philipp Baumann, et al.
Children (Basel, Switzerland)|November 27, 2024
Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill ChildrenRafael Muff, Verena Gotta, Vera Jaeggi, et al.
Anti-Cancer Drugs|October 1, 2011
Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myelomaPhilipp Baumann, Laura Schneider, Sonja Mandl-Weber, et al.
Frontiers in Plant Science|November 12, 2020
A Non-destructive Method to Quantify Leaf Starch Content in Red CloverLea Antonia Frey, Philipp Baumann, Helge Aasen, et al.
Experimental Cell Research|August 3, 2007
Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cellsPhilipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, et al.
Pageof 7